Structural

Redo SAVR/TAVR Explant: What Is the Current Role of Surgery in Managing Failing Surgical or Transcatheter Valves?

16 min.

Redo TAVR: Procedural Planning and Technical Considerations

15 min.

Updates on the Outcomes of TAV-in-TAV

7 min.

Management of Small Surgical Valves: Should We Continue to Perform Valve Fracture? Which Valves Should Be Fractured?

21 min.

Prevention and Management of Coronary Obstruction in VIV-TAVR

9 min.

Updates on the Outcomes of TAV-in-SAV

8 min.

CT Imaging Essentials for Planning Aortic Valve Reintervention

13 min.

Redo TAV: Summary

8 min.

Redo TAV: Coronary Risk Mitigation

9 min.

Redo TAV: Additional Case-Based Analysis and Procedure Examples

4 min.

Redo TAV Procedure – Edited Case & Post Redo-TAV CT findings

10 min.

Redo TAV: Unified Terminology and Concepts

9 min.

Challenges in Redo TAV

8 min.

Redo TAV: Case Presentation and CT Analysis – Step-by-step Using APP

10 min.

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

7 min.

Outcomes of TAVR and SAVR in Bicuspid AS: Data From the STS/TVT Registry

7 min.

TAVR Techniques in Bicuspid Anatomy: Valve Selection, Sizing, and Positioning

9 min.

CT Guidance for TAVR Planning in Bicuspid AS in 2023

6 min.

We Need an RCT, and Here Is How I Would Like to Design It

7 min.

Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

2 min.

Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management

10 min.

Index TAVR in Young Patients With Bicuspid AS is Better for Lifetime Management

5 min.

Case Presentation: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

5 min.

Case Presentation 2: Failed Annular TAVR and ‘How To Do’ TAV-in-TAV (e.g. With BASILICA in Sapien)

11 min.

Case Presentation 1: Failed Supra-Annular TAVR and ‘How To Do’ TAV-in-TAV (Sapien in Evolut)

7 min.

TAVR Failure Modes, Anatomic Considerations and New Nomenclature for TAV-in-TAV Procedures

16 min.

BASILICA complicated by coronary obstruction

14 min.

Leaflet laceration using "Percutaneous balloon valvotomy": Utilizing UNICORN (Undermining Coronary Obstruction with Radiofrequency Needle ablation) for TAVR in TAVR.

13 min.

Unusual cause of myocardial infarction following transcatheter aortic valve replacement

8 min.

Next Frontier Insights: THV Deformation After ViV Procedures – Incidence and Implications

6 min.

SPOTLIGHT LECTURE: Leaflet Modification Techniques: BASILICA and Other Emerging Technologies

12 min.

Case Presentation 3: When is Redo AVR the Right Decision

8 min.

Case Presentation 2: Considerations in Stentless/Homograft Failure ViV TAVR

9 min.

Case Presentation 1: Optimizing ViV TAVR With Bioprosthetic Valve Failure in a Stented Surgical Valve

14 min.

The Essential Aortic ViV TAVR Update: Procedural Strategies and Current Clinical Results

9 min.

A Transcatheter Mitral Valve-in-Valve Replacement In Failed Bioprosthetic Surgical Valve: A Promising Approach

9 min.

Case Presentation:  Bicuspid Tips and Tricks

11 min.

CT Guidance for TAVR Planning in Bicuspid AS

15 min.

Counter-Point: TAVR BEV

5 min.

Contra-Point: TAVR SEV

5 min.

The Hangzhou Solution for Treating Bicuspid AS: Lessons From Asia

8 min.

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

14 min.

Valve-in-Valve: A Brief Primer

14 min.

SPOTLIGHT INNOVATION LECTURE: From BASILICA to CATHEDRAL: The Growing Role of Leaflet Modification in the Structural Heart Field

7 min.

Valve-in-Valve TAVR: Advanced Technique for Challenging Cases

8 min.

TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning

9 min.

Challenging BAV Anatomy for TAVR – Who NOT to Treat

6 min.

Surgical Root Enlargement – Techniques, Results, and Limitations

8 min.

Is TAV–in–Valve (Repeatability) More Important than Leaflet Durability?

9 min.

NEW TAVR Platforms - ACURATE NEO 2

10 min.

New TAVR Platforms - PORTICO NAVITOR FLEX-NAV

15 min.